Ralph Preiss

Selexipag for the Treatment of Pulmonary Arterial Hypertension

Olivier Sitbon, Richard N. Channick, Kelly Chin et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study

Rieke Alten, Juan J. Gómez‐Reino, Patrick Durez et al. · BMC Musculoskeletal Disorders · 2011 · 151 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension

Seán Gaine, Kelly Chin, Gerry Coghlan et al. · European Respiratory Journal · 2017 · 140 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13

Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study

Isabelle Koné‐Paut, Helen J. Lachmann, Jasmin Kuemmerle‐Deschner et al. · Arthritis Research & Therapy · 2011 · 134 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality

Vallerie V. McLaughlin, Marius M. Hoeper, Richard N. Channick et al. · Journal of the American College of Cardiology · 2018 · 111 citations · Full text

Medicine, Biostatistics, Cardiology +9